Products
-
- BBB DamageCell Death and ApoptosisNeuroinflammationNeuronal Damage and RepairOxidative StressVascular Mechanisms
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human KCNQ1 ELISA Kit (AC3014)
Cat.#: ASET-1603
Specifications
Description Human KCNQ1 ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of human KCNQ1 concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 7.81 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 100-1600 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2330 Human POMC ELISA Kit (AC3741) Quantitative inquiry ASET-2360 Human Stomatin ELISA Kit (AC3771) Quantitative inquiry ASET-1315 Mouse COMT ELISA Kit (AC2726) Quantitative inquiry ASET-1905 Human Myelin Basic Protein ELISA Kit (AC3316) Quantitative inquiry ASET-1152 Human GAPDH ELISA Kit (AC2563) Quantitative inquiry ASET-1380 Rat FGF2 ELISA Kit (AC2791) Quantitative inquiry ASET-2054 Mouse Nestin ELISA Kit (AC3465) Quantitative inquiry ASET-1252 Human Granuphilin ELISA Kit (AC2663) Quantitative inquiry ASET-2218 Human POMT1 ELISA Kit (AC3629) Quantitative inquiry ASET-1871 Mouse Synaptotagmin 1 ELISA Kit (AC3282) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
0Inquiry Basket